Previous Next

2024-02-29

The IL-1 signaling pathway in bladder cancer

Oncology

In bladder carcinoma, there is an imbalance between IL-1 and the IL-1 receptor antagonist. This signaling pathway is therefore of interest for the development of new therapeutic strategies. In this study, we evaluated the expression profiles and prognostic role of IL-1-beta and IL-1 receptor antagonist (IL-1 RA) in invasive bladder carcinoma. The study was conducted on two independent cohorts of 92 and 102 patients who had undergone radical cystectomy. IL-1β and IL-1RA were significantly overexpressed in invasive versus benign urothelium in both cohorts. IL-1-beta protein expression was of prognostic significance in bladder cancer.

Source(s) :
Marko Vukovic et al. Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive Bladder Cancer-An Exploratory Analysis of Clinical and Tumor Biological Significance. Int J Mol Sci. 2024 Feb 19;25(4):2447. ;

Last press reviews


MicroRNAs & Microbiota: An Inflammatory Duo?

#MicroRNA  #Microbiota  #IBD  #Immunotherapy  #Innov...

Vaccine-derived poliovirus: a threat under surveillance

#Poliovirus  #InfectiousDiseases  #Vaccine  #Vaccination&...

HBsAg and immunity: a barrier or an ally against hepatitis B?

#InfectiousDiseases  #Hepatitis  #HepatitisB  #Immunity